• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[症状性颅内动脉狭窄治疗中翼展支架内再狭窄的预测因素]

[Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis].

作者信息

Ma Min-min, Yin Qin, Xu Ge-lin, Zhang Ren-liang, Zhu Shuang-gen, Fan Xin-ying, Zhu Wu-sheng, Liu Xin-feng

机构信息

Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2011 May 24;91(19):1303-7.

PMID:21756754
Abstract

OBJECTIVE

To analyze the predictors of Wingspan in-stent restenosis (ISR) for the treatment of symptomatic intracranial arterial stenosis.

METHODS

Between January 2007 and November 2009, 42 patients with symptomatic intracranial arterial stenosis registered in Nanjing stroke registry program (NSRP) were treated with Wingspan stent system. Clinical and follow-up results were retrospectively analyzed. They were divided into the non-restenosis and restenosis groups according to their follow-up imaging data. ISR was defined as > 50% stenosis within 5 mm or adjacent to stent or an absolute luminal loss > 20%. The analysis of stepwise multivariate Cox regression was performed to evaluate the independent predictive factors.

RESULTS

ISR was found in 15 patients (15/42, 35.7%) with 16 lesions (16/43, 37.2%) at a median follow-up period of 7 months (range: 4 - 23). Diabetes (HR = 0.281; 95%CI = 0.088 - 0.898; P = 0.032) and stent diameter (HR = 0.213; 95%CI = 0.049 - 0.918; P = 0.038) were two independent predictors for ISR.

CONCLUSION

Diabetes and stent diameter may be two independent predictors for ISR after a treatment of Wingspan system.

摘要

目的

分析使用Wingspan支架治疗有症状的颅内动脉狭窄时支架内再狭窄(ISR)的预测因素。

方法

2007年1月至2009年11月期间,对南京卒中登记项目(NSRP)中登记的42例有症状的颅内动脉狭窄患者采用Wingspan支架系统进行治疗。对临床和随访结果进行回顾性分析。根据随访影像资料将患者分为无再狭窄组和再狭窄组。ISR定义为支架内或支架附近5mm范围内狭窄>50%或绝对管腔丢失>20%。采用逐步多因素Cox回归分析评估独立预测因素。

结果

15例患者(15/42,35.7%)出现ISR,共16处病变(16/43,37.2%),中位随访时间为7个月(范围:4 - 23个月)。糖尿病(HR = 0.281;95%CI = 0.088 - 0.898;P = 0.032)和支架直径(HR = 0.213;95%CI = 0.049 - 0.918;P = 0.038)是ISR的两个独立预测因素。

结论

糖尿病和支架直径可能是Wingspan系统治疗后ISR的两个独立预测因素。

相似文献

1
[Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis].[症状性颅内动脉狭窄治疗中翼展支架内再狭窄的预测因素]
Zhonghua Yi Xue Za Zhi. 2011 May 24;91(19):1303-7.
2
Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.翼展支架内再狭窄和血栓形成:发生率、临床表现及处理
Neurosurgery. 2007 Sep;61(3):644-50; discussion 650-1. doi: 10.1227/01.NEU.0000290914.24976.83.
3
Angiographic patterns of Wingspan in-stent restenosis.Wingspan支架内再狭窄的血管造影模式。
Neurosurgery. 2008 Jul;63(1):23-7; discussion 27-8. doi: 10.1227/01.NEU.0000335067.53190.A2.
4
Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.西罗莫司与紫杉醇洗脱支架治疗冠状动脉支架内再狭窄的比较。
Am J Cardiol. 2006 Apr 15;97(8):1182-7. doi: 10.1016/j.amjcard.2005.11.034. Epub 2006 Mar 9.
5
Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.药物洗脱支架再狭窄患者行经皮冠状动脉介入治疗后靶病变血运重建的预测因素。
J Cardiol. 2010 May;55(3):391-6. doi: 10.1016/j.jjcc.2010.01.003. Epub 2010 Feb 7.
6
Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases.51 例症状性颅内 50-99%动脉粥样硬化患者采用 Wingspan 支架治疗的长期临床和血管造影结果:单中心经验。
J Neurointerv Surg. 2009 Jul;1(1):40-3. doi: 10.1136/jnis.2009.000331. Epub 2009 Jul 3.
7
Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis.症状性颅内动脉粥样硬化行球囊扩张支架置入术后支架内再狭窄的预测因素。
Eur J Vasc Endovasc Surg. 2010 Oct;40(4):499-506. doi: 10.1016/j.ejvs.2010.05.007. Epub 2010 Jun 15.
8
Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis.Wingspan 支架治疗颅内动脉粥样硬化性狭窄:支架内再狭窄的临床转归和危险因素。
Neurosurgery. 2013 Apr;72(4):596-604; discussion 604. doi: 10.1227/NEU.0b013e3182846e09.
9
Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.支架边缘原位再狭窄的治疗意义。来自再狭窄支架内球囊血管成形术与择期支架置入术(RIBS)随机试验的见解。
Eur Heart J. 2004 Oct;25(20):1829-35. doi: 10.1016/j.ehj.2004.07.019.
10
Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.药物洗脱支架治疗支架内再狭窄的临床结果:前瞻性多中心德国 DES.DE 注册研究第一阶段的结果。
EuroIntervention. 2011 Jun;7(2):201-8. doi: 10.4244/EIJV7I2A34.

引用本文的文献

1
Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).SAMMPRIS试验(颅内狭窄支架置入与积极药物治疗预防复发性卒中)中颅内血管成形术和支架置入术后的非手术性症状性梗死和支架内再狭窄
Stroke. 2017 Jun;48(6):1501-1506. doi: 10.1161/STROKEAHA.116.014537. Epub 2017 Apr 28.
2
Stenting in Intracranial Stenosis: Current Controversies and Future Directions.颅内狭窄的支架置入术:当前争议与未来方向
Curr Atheroscler Rep. 2015 Aug;17(8):48. doi: 10.1007/s11883-015-0527-4.